Associate Professor, Medicine, Case Western Reserve University School of Medicine
Hematology
Dr. Ronald M. Sobecks, MD
|
|
Give Review
Ronald Sobecks is an expert in the field of Hematology. He researched medicine at Case Western Reserve University School of Medicine. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Ronald Sobecks is also a published physician. He has 97 paper published. The most recent paper is: Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation. Doctor Ronald M. Sobecks, MD is registered with Medicare and accepts Medicare payments.
Publications
- Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic Cell transplantation.
- Racial differences in allogeneic hematopoietic Cell transplantation outcomes among African Americans and whites.
- Cyclosporine in combination with mycophenolate mofetil versus methotrexate for Graft versus host disease prevention in myeloablative HLA-identical sibling donor alloge...
- Synergistic Effect of Major Histocompatibility Complex Class I-Related Chain A and Human Leukocyte Antigen-DPB1 Mismatches in Association with Acute Graft-versus-Host ...
- Quality of life and outcomes in patients⩾60 years of age after allogeneic hematopoietic Cell transplantation.
- Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic Cell transplantation.
- Outcomes of Human Leukocyte Antigen-Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia: Myeloablative Versus Reduced-Intensity Co...
- Does Total Body Irradiation Conditioning Improve Outcomes of Myeloablative Human Leukocyte Antigen-Identical Sibling Transplantations for Chronic Lymphocytic Leukemia?
- Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hema...
- Donor T-Cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem Cell transplant.
- Mature results of MM-011: A phase I/II trial of liposomal doxorubicin, Vincristine, Dexamethasone, and Lenalidomide combination therapy followed by lenalidomide mainte...
- Defining Incidence, Risk Factors, and Impact on Survival of Central Line-Associated Blood Stream Infections Following Hematopoietic Cell Transplantation in Acute Myelo...
- Expression of phosphorylated signal transducer and activator of transcription 5 is associated with an increased risk of death in Acute myeloid leukemia.
- Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed Acute lymphoblastic leukemia.
- Secondary solid Cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.
- Molecular analysis of alloreactive CTL post-hemopoietic stem Cell transplantation.
- High disease burden is associated with poor outcomes for patients with Acute myeloid leukemia not in remission who undergo unrelated donor cell transplantation.
- Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid Leukemia: the University of Chicago series.
- BU- vs TBI-based conditioning for adult patients with ALL.
- Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and Leukemia.
- Apheresis days required for harvesting CD34+ Cells predicts hematopoietic recovery and survival following autologous transplantation.
- p53 independent epigenetic-differentiation treatment in xenotransplant models of Acute myeloid leukemia.
- Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT.
- 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem Cell transplantation.
- A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin''s Lymphoma.
- Are backup BM harvests worthwhile in unrelated donor allogeneic transplants?
- Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation.
- Comparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell Lymphoma according to previous therapy with rituximab.
- Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for Acute myelogenous leukemia.
- Double-negative regulatory T Cells induce allotolerance when expanded after allogeneic haematopoietic stem Cell transplantation.
- Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-Cell complete donor chimerism in related donor nonmyeloablative allogeneic hem...
- Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular Lymphoma.
- Severe mucositis is associated with reduced survival after autologous stem Cell transplantation for lymphoid malignancies.
- Patients mobilizing large numbers of CD34+ Cells (''super mobilizers'') have improved survival in autologous stem Cell transplantation for lymphoid malignancies.
- Autologous hematopoietic stem cell transplantation in peripheral T-cell Lymphoma using a uniform high-dose regimen.
- Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw ligand groups for killer immunoglobulin-like...
- Imidazole antifungals Miconazole and Econazole induce apoptosis in mouse lymphoma and human T cell Leukemia cells: regulation by Bcl-2 and potential role of calcium.
- A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative a...
- Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients wit...
- Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant.
- Syngeneic Graft-versus-host disease: a report of two cases and literature review.
- Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell Lymphoma: graft content and post transplant recovery predict survival.
- High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with Acute myeloid l...
- Steroids prevent engraftment Syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection.
- Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course.
- CD8+ T-Cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
- Autologous peripheral blood progenitor cell transplantation for transformed diffuse large-cell Lymphoma.
- Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem Cell transplantation.
- Prognostic importance of the axillary lymph node ratio in autologous transplantation for high-risk stage II/III Breast cancer.
- A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem Cell transplantation for the treatment of advanced hematolo...
- Myelodysplasia and Acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.
- High-dose chemotherapy with autologous stem-Cell support for germ Cell tumors: a critical review.
- Prevalence and classification of Anemia in elective orthopedic surgery patients: implications for blood conservation programs.
- Etoposide (VP-16) plus G-CSF mobilizes different dendritic Cell subsets than does G-CSF alone.
- A multivariable analysis of factors influencing mucositis after autologous progenitor Cell transplantation.
- The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem Cell mobilization.
- Autologous hematopoietic cell transplantation non-Hodgkin''s Lymphoma: 100 month follow-up.
- Fatal West Nile Virus infection after rituximab/fludarabine--induced remission for non-Hodgkin's Lymphoma.
- A case of zygomycosis and invasive candidiasis involving the epiglottis and tongue in an immunocompromised patient.
- Molecular TCR diagnostics can be used to identify shared clonotypes after allogeneic hematopoietic stem Cell transplantation.
- A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant Diseases.
- Long-term outcome of Hodgkin Disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation.
- High-dose busulfan and the risk of pulmonary mortality after autologous stem Cell transplant.
- Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and Acute myelogenous leukemia.
- The role of post-remission chemotherapy for older patients with Acute myelogenous leukemia.
- Impact of socioeconomic status and distance from treatment center on survival in patients receiving remission induction therapy for newly diagnosed Acute myeloid leuke...
- Impact of remission induction chemotherapy on survival in older adults with Acute myeloid leukemia.
- White blood cell count nadir following remission induction chemotherapy is predictive of outcome in older adults with Acute myeloid leukemia.
- Increased C-kit intensity is a poor prognostic factor for progression-free and oVerall survival in patients with newly diagnosed AML.
- A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed Acute myeloid leukemia.
- Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for Lymphoma.
- Time to post-remission therapy is an independent prognostic factor in adults with Acute lymphoblastic leukemia.
- Timed sequential induction chemotherapy and risk-adapted postremission therapy for Acute myelogenous leukemia.
- Survival and predictors of outcome in patients with Acute leukemia admitted to the intensive care unit.
- OCT-2 expression and OCT-2/BOB.1 co-expression predict prognosis in patients with newly diagnosed Acute myeloid leukemia.
- A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple Myeloma.
- Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin Lymphoma with busulfan, cyclophosphamide and e...
- Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in Acute myeloid leukaemia.
- A prognostic scoring system for adult patients less than 60 years of age with Acute lymphoblastic leukemia in first relapse.
- Late mortality and relapse following BuCy2 and HLA-identical sibling marrow transplantation for chronic myelogenous Leukemia.
- Elevated pretransplant ferritin is associated with a lower incidence of Chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematop...
- Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem Cell transplant correlates with donor killer immu...
- The non-relapse mortality rate for patients with diffuse large B-cell Lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and...
- Vitamin D level after allogeneic hematopoietic stem Cell transplant.
- Autologous stem cell transplant for early relapsed/refractory Hodgkin Lymphoma: results from two transplant centres.
- Histone H4 acetylation by immunohistochemistry and prognosis in relapsed Acute lymphocytic leukaemia (ALL).
- Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization o...
- Predictions in the face of clinical reality: HistoCheck versus high-risk HLA allele mismatch combinations responsible for severe Acute graft-versus-host disease.
- Race and intensity of post-remission therapy in Acute myeloid leukemia.
- Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult Acute lymphoblastic leukemia (ALL) patients.
- Effect of post-remission chemotherapy preceding allogeneic hematopoietic cell transplant in patients with Acute myeloid leukemia in first remission.
- Impact of weekend admissions on quality of care and outcomes in patients with Acute myeloid leukemia.
- Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplants.
- A Phase II trial of gemcitabine and mitoxantrone for patients with Acute myeloid leukemia in first relapse.
- Multiple unit umbilical cord blood transplantation with total body irradiation, etoposide and antithymocyte globulin for adult haematological malignancy patients.
- A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary Acute myeloid leukemia.
Schools
Case Western Reserve University School of Medicine
University Hosps
University of Chicago
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Breast Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Chicago -
Case Western Reserve University - University Hospitals -
Case Western Reserve University School of Medicine
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1023075835 | |
| NPPES Provider LastName | SOBECKS | |
| NPPES Provider FirstName | RONALD | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 850.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1023075835 |
| Last Name Of The Provider | SOBECKS |
| First Name Of The Provider | RONALD |
| View All |
Similar Doctors
|
|
Dr. Paula M. Silverman, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Paula Silverman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gil S. Peleg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Waqas Rehman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Erica L. Campagnaro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meredith E. Driscol, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Evi Stavrou, MD |
|
|
Dr. Ming Chi, MD |
|
|
Dr. Ann Tan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tycel J. Phillips, MD
This Doctor is OpenDoctor Recommended.
|